Gw&K Investment Management, LLC Veracyte, Inc. Transaction History
Gw&K Investment Management, LLC
- $11.7 Billion
- Q3 2024
A detailed history of Gw&K Investment Management, LLC transactions in Veracyte, Inc. stock. As of the latest transaction made, Gw&K Investment Management, LLC holds 1,429,198 shares of VCYT stock, worth $63 Million. This represents 0.42% of its overall portfolio holdings.
Number of Shares
1,429,198
Previous 1,405,301
1.7%
Holding current value
$63 Million
Previous $30.5 Million
59.76%
% of portfolio
0.42%
Previous 0.28%
Shares
20 transactions
Others Institutions Holding VCYT
# of Institutions
311Shares Held
81.5MCall Options Held
134KPut Options Held
13.3K-
Black Rock Inc. New York, NY7.79MShares$343 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.75MShares$341 Million0.0% of portfolio
-
Artisan Partners Limited Partnership Milwaukee, WI5.02MShares$221 Million0.27% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl4.92MShares$217 Million1.59% of portfolio
-
Wellington Management Group LLP Boston, MA4.23MShares$187 Million0.03% of portfolio
About VERACYTE, INC.
- Ticker VCYT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 71,575,904
- Market Cap $3.15B
- Description
- Veracyte, Inc. operates as a diagnostics company worldwide. The company offers Afirma Genomic Sequencing Classifier and Xpression Atlas, which are used to determine patients with indeterminate results are benign to avoid unnecessary surgery; Decipher Prostate Biopsy and Radical Prostatectomy for prostate cancer diagnosis; Prosigna Breast Cancer ...